Breast Cancer
Side Effects Of Treatment Offer Research Direction
Published in Cancer Weekly, July 17th, 2001
In a sweeping review of 25 years of research into the side effects of adjuvant treatment for breast cancer (chemotherapy and/or radiation following surgery), an Ohio State University cancer specialist concludes that adjuvant therapy reduces mortality, most of the side effects are reversible, and there is little or no increase in long-term cardiac toxicity and second cancers using current regimens.
The conclusions were published in the June 28, 2001, edition of the New England Journal of Medicine. Dr. Charles L. Shapiro, director of breast medical oncology at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, conducted the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2001-07-17)
More Articles from Cancer Weekly
- Colorectal Cancer
Vascular Modulator May Also Be Prognostic Indicator - Renal Cancer
Particle Embolization Reduces Blood Loss During Spinal Metastasis Surgery - Adverse Drug Effects
Interferon Is Cause Of Retinal Disease In Patients Treated For Melanoma - Breast Cancer
Older Women At Greater Risk If They Have High Bone Density - Non-Small Cell Lung Cancer
New Model Incorporates Biological Markers To Predict Patient Outcomes - Ovarian Cancer
Some Lipids Regulate Production of Proangiogenic Cytokine Interleukin-8 - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
